Skip to main content
eScholarship
Open Access Publications from the University of California

Dermatology Online Journal

Dermatology Online Journal bannerUC Davis

Ocrelizumab-induced psoriasiform dermatitis in a patient with multiple sclerosis

  • Author(s): Darwin, Evan;
  • Romanelli, Paolo;
  • Lev-Tov, Hadar
  • et al.
Abstract

Multiple Sclerosis (MS) is a chronic autoimmune disease that presents with a wide variety of sensory and motor deficiencies. New medications targeting B cells have been approved to treat MS, but the side effect profile has not been widely explored. Herein, we report a case of drug-induced psoriasiform dermatitis following ocrelizumab treatment. Physicians should be cognizant of this possible side effect in patients receiving treatment for MS.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View